Security key
71715X203
PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)
CUSIP: 71715X203
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 567,925
- Total 13F value
- $709,896
- Share change
- -32,465
- Put/Call ratio
- 15%
- SEC-reported price per share
- $1.25
- Number of holders
- 21
- Value change
- -$40,591
- Number of buys
- 8
- Number of sells
- 7
- Shares outstanding
- 10,666,413
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
21
Top holders
10
PMCB full security history
Ownership snapshot
Full 13F holder table
PharmaCyte Biotech, Inc. SEC filings
PharmaCyte Biotech, Inc. company facts
PharmaCyte Biotech, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Ayrton Capital LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Ayrton Capital LLC
Showing 1-6 of 15 holder rows.
Quick read
Ayrton Capital LLC leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership
Top 5
Ayrton Capital LLC
9.9%
VANGUARD GROUP INC
1.8%
GEODE CAPITAL MANAGEMENT, LLC
1.5%
EQUITEC PROPRIETARY MARKETS, LLC
0.78%
RENAISSANCE TECHNOLOGIES LLC
0.46%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
9.9%
|
$967,625
774,100 shares
|
$0 | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.8%
|
$298,200
192,387 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.5%
|
$255,364
164,736 shares
|
— | 31 Dec 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
Company
|
0.78%
|
$129,881
82,727 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.46%
|
$77,401
49,300 shares
|
— | 31 Dec 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.32%
|
$53,446
34,481 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
567,925
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
21
Q1 2025 holders
21
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|